Tag: Nipocalimab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Nipocalimab

Sustained Control with Investigational Monoclonal Antibody for Myasthenia Gravis | MDedge

Added to Collection on: 2024-10-17 16:50:21

Tags for this article:

Clinical research
Autoimmune diseases
Myasthenia gravis
AstraZeneca
Nipocalimab
Placebo
Autoantibody
Amgen

Click the tags to see associated articles and topics

View Article Details
Nipocalimab Gets Priority Review for Generalized Myasthenia Gravis - eMPR.com

Added to Collection on: 2025-01-09 20:44:56

Tags for this article:

Autoimmune diseases
Monoclonal antibodies
Nipocalimab
Myasthenia gravis
GMG
Autoantibody
Orphan drugs
Immunosuppressants
Neuromuscular junction disease
Efgartigimod alfa/hyaluronidase

Click the tags to see associated articles and topics

View Article Details
Novel Therapies in Management of Haemolytic Disease of the Fetus and Newborn, reveals research

Added to Collection on: 2025-03-28 15:02:02

Tags for this article:

Transfusion medicine
Acquired hemolytic anemia
Neonatology
Obstetrics
Polyclonal antibodies
Hemolytic disease of the newborn
Rh disease
Intrauterine transfusion
Nipocalimab
Rho(D) immune globulin
Hydrops fetalis
Immunoglobulin therapy

Click the tags to see associated articles and topics

View Article Details
FDA Approves Imaavy for Long Term Treatment of Generalized Myasthenia Gravis

Added to Collection on: 2025-05-01 21:07:04

Tags for this article:

Autoimmune diseases
Monoclonal antibodies
Myasthenia gravis
Nipocalimab
Autoantibody
Neonatal fragment crystallizable receptor
Acetylcholine receptor
Acetylcholine
Gravis
GMG
Congenital myasthenic syndrome
Neuromuscular junction disease
United States

Click the tags to see associated articles and topics

View Article Details
Johnson & Johnson's IMAAVY Gets FDA Approval, Taking on Top Players in Myasthenia ...

Added to Collection on: 2025-05-22 21:50:43

Tags for this article:

Orphan drugs
Monoclonal antibodies
Nipocalimab
Myasthenia gravis
Eculizumab
GMG
Efgartigimod alfa/hyaluronidase
Efgartigimod alfa
Gravis
Neonatal fragment crystallizable receptor
Batoclimab
Rozanolixizumab
Japan
United States

Click the tags to see associated articles and topics

View Article Details
J&J's Nipocalimab Advances in gMG Treatment: Strategic Positioning in the Neuromuscular ...

Added to Collection on: 2025-09-19 17:43:56

Tags for this article:

Orphan drugs
Monoclonal antibodies
Autoimmune diseases
Nipocalimab
Myasthenia gravis
Neonatal fragment crystallizable receptor
GMG
Eculizumab
Gravis
Efgartigimod alfa
Food and Drug Administration
Johnson & Johnson
Johnson & Johnson's

Click the tags to see associated articles and topics

View Article Details
Myasthenia Gravis Market Outlook 2034 – Clinical Trials, Market Size, Medication ...

Added to Collection on: 2025-09-29 17:07:35

Tags for this article:

Orphan drugs
Monoclonal antibodies
Autoimmune diseases
Myasthenia gravis
Acetylcholinesterase inhibitors
Quaternary ammonium compounds
Nipocalimab
Thymectomy
Gravis
Efgartigimod alfa
MuSK protein
Pyridostigmine
Germany
Efgartigimod IV
Italy
Takeda
Kyverna Therapeutics
Dianthus Therapeutics
France
Japan
United States
United Kingdom
cartesian therapeutics
COUR Pharmaceuticals
AstraZeneca
HOFFMANN - LA ROCHE
Spain
Regeneron Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Book a Demo